Immediate Impact
22 standout
Citing Papers
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
2022 Standout
Works of Andrew A. Marchetti being referenced
KRAS mutations in colorectal cancer patients in Italy: Results from the KRAS aKtive program.
2011
P53 alterations are predictive of aggressiveness in ovarian carcinomas
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrew A. Marchetti | 133 | 179 | 34 | 77 | 15 | 253 | |
| Marco Gaffi | 167 | 99 | 28 | 168 | 14 | 301 | |
| Michelle Koski | 204 | 194 | 12 | 76 | 20 | 286 | |
| Nancy A. Little | 153 | 175 | 20 | 69 | 13 | 313 | |
| P. Chinet-Charrot | 148 | 73 | 40 | 57 | 10 | 233 | |
| Chiu‐Lin Wang | 119 | 123 | 112 | 50 | 21 | 307 | |
| Hugh C. Bredin | 181 | 70 | 33 | 77 | 20 | 277 | |
| Simon D. Wu | 112 | 90 | 30 | 125 | 11 | 326 | |
| Tim Christmas | 116 | 52 | 6 | 88 | 18 | 213 | |
| Tatsuro Murase | 202 | 60 | 20 | 75 | 23 | 310 | |
| Marcello Pellegrino | 131 | 112 | 88 | 18 | 15 | 276 |
All Works
Loading papers...